Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Ethical Issues in Cluster Randomized Trials Conducted in Low- a Nd Middle-Income Countries: An Analysis of Two Case Studies Publisher Pubmed



Choko AT1, 2 ; Roshandel G3 ; Conserve DF4 ; Corbett EL1, 5 ; Fielding K2, 6 ; Hemming K7 ; Malekzadeh R8 ; Weijer C9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi
  2. 2. Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
  3. 3. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
  4. 4. Department of Health Promotion, Education and Behaviour, University of South Carolina, Columbia, United States
  5. 5. Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom
  6. 6. School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
  7. 7. Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom
  8. 8. Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. Rotman Institute of Philosophy, Western University, London, Canada

Source: Trials Published:2020


Abstract

Background: Cluster randomized trials are common in health research in low- A nd middle-income countries raising issues that challenge interpretation of standard ethical guidelines. While the Ottawa Statement on the ethical design and conduct of cluster randomized trials provides guidance for researchers and research ethics committees, it does not explicitly focus on low- A nd middle-income settings. Main body: In this paper, we use the lens of the Ottawa Statement to analyze two cluster randomized trials conducted in low- A nd middle-income settings in order to identify gaps or ethical issues requiring further analysis and guidance. The PolyIran trial was a parallel-arm, cluster trial examining the effectiveness of a polypill for prevention of cardiovascular disease in Golestan province, Iran. The PASTAL trial was an adaptive, multistage, parallel-arm, cluster trial evaluating the effect of incentives for human immunodeficiency virus self-testing and follow-up on male partners of pregnant women in Malawi. Through an in-depth case analysis of these two studies we highlight several issues in need of further exploration. First, standards for verbal consent and waivers of consent require methods for operationalization if they are to be employed consistently. Second, the appropriate choice of a control arm remains contentious. Particularly in the case of implementation interventions, locally available care is required as the comparator to address questions of comparative effectiveness. However, locally available care might be lower than standards set out in national guidelines. Third, while the need for access to effective interventions post-trial is widely recognized, it is often not possible to guarantee this upfront. Clarity on what is required of researchers and sponsors is needed. Fourth, there is a pressing need for ethics education and capacity building regarding cluster randomized trials in these settings. Conclusion: We identify four issues in cluster randomized trials conducted in low- A nd middle-income countries for which further ethical analysis and guidance is required. © 2020 The Author(s).
Experts (# of related papers)